Stay updated with breaking news from Anders Kuhnau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global phenomenon. They’ve won over the rich and famous, generated billions in sales and blown open a new market for weigh...
There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global phenomenon. They’ve won over the rich and famous, generated billions in sales and blown open
“When you have superpowers, you have super responsibility," says CEO Lars Fruergaard Jorgensen.
(Bloomberg) -- There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global phenomenon. They’ve won over the rich and famous, generated billions in sales and blown open a new market for weight loss drugs, which Goldman Sachs estimates will reach $100 billion a year by 2030.Most Read from BloombergTesla Axes Supercharger Team in Blow to Broader EV MarketNYC Police Break Up Columbia Protest and Clashes Erupt at UCLAAmazon Posts Strongest Cloud Sales Growth in a Year on AI D
In the wake of Ozempic and Wegovy's global dominance, Novo Nordisk emerges as a transformative force in Denmark's socio-economic fabric.